Comments for Big Day. Big Movers in Bio - JAZZ, HEB, MNTA, MBLX and OCLS at http://www.biomedreports.com , comment 1 to 6 out of 6 comments http://www.biomedreports.com Wed, 08 Feb 2012 03:22:15 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/200906251628/big-day-big-movers-in-bio-jazz-heb-mnta-mblx-and-ocls.html#comment-431 My I suggest that you go to OCLS Yahoo message board, and read my comments and questions and researched links. Much work was done and posted on that message board. It would save you time by looking at those readily referenced sources. - H. Grant Tue, 30 Jun 2009 00:58:00 +0100 http://www.biomedreports.com/200906251628/big-day-big-movers-in-bio-jazz-heb-mnta-mblx-and-ocls.html#comment-417 What is the difference between thw OTC and RX forms? - Stephen Mathew Sun, 28 Jun 2009 23:37:01 +0100 http://www.biomedreports.com/200906251628/big-day-big-movers-in-bio-jazz-heb-mnta-mblx-and-ocls.html#comment-406 Thanks to everyone who submitted questions both here and via email. We'll certainly address them with during our interview. - M.E.Garza Fri, 26 Jun 2009 08:12:12 +0100 http://www.biomedreports.com/200906251628/big-day-big-movers-in-bio-jazz-heb-mnta-mblx-and-ocls.html#comment-402 Here's a few questions for Hoji. What is the general status of the Phase III trials? · Is the company moving this trial forward? If so, how, what’s the schedule, expected FDA submission, response period and estimated approval? Are patient groups being formed yet? · Are the anticipated “clearances” just more label claims or are they something else? · Label expansion is good, but shouldn’t the Phase III open up more revenue streams? What is the strategy with the label expansion vs. Phase III? · Is it correct to assume that the label expansions are an effort to build some revenue to pay for the Phase III? · Are there any staff concerns moving through the Phase III trials? · What is the lack of the Phase III approval preventing Oculus from doing? Lastly, does Hoji think thestreet's articles and timing are suspicious in controlling the price of the stock for shorters? - sdt1 Fri, 26 Jun 2009 01:07:36 +0100 http://www.biomedreports.com/200906251628/big-day-big-movers-in-bio-jazz-heb-mnta-mblx-and-ocls.html#comment-398 Please ask the CEO of Oculus if he would consider a lawsuit against Adam Feuerstein. Either Feuerstein's allegations against Oculus are true or they are slander with a strong agenda. - sallymander Thu, 25 Jun 2009 21:41:03 +0100 http://www.biomedreports.com/200906251628/big-day-big-movers-in-bio-jazz-heb-mnta-mblx-and-ocls.html#comment-389 Thanks for the update on HEB. Great article. - Mary Davila Thu, 25 Jun 2009 10:26:09 +0100